Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Fens, K. F. van der Sluijs, M. A. van de Pol, R. Lutter, S. L. Johnston, P. J. Sterk (Amsterdam, Netherlands; London, United Kingdom). Exhaled molecular patterns change after experimental rhinovirus 16 infection in asthma. Eur Respir J 2011; 38: Suppl. 55, 1692

Member's Comments

No comment yet.

Related content which might interest you: Assessment of virus-induced wheeze by exhaled breath molecular profiling in pre-school children, the EUROPA-study Source: Annual Congress 2010 - Paediatric asthma risk factors Year: 2010 External validation of exhaled breath molecular profiling in identifying COPD and asthma Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010 Is the average exhaled nitric oxide concentration (FeNO) effective in detecting respiratory rhinovirus (RV) infections? Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020 Exhaled particles in healthy subjects and asthma patients – a new method for analysis of exhaled air Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Low exhaled nitric oxide levels in infants with respiratory symptoms in the first 2 months of life Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 Exhaled NO and exhaled breath condensate pH in the assessment of asthma control: a real-life study Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma Year: 2009 Exhaled breath molecular profiling in measuring inflammatory status in COPD Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Exhaled breath temperature in asthma Source: Eur Respir J 2003; 21: 195 Year: 2003 Exhaled breath condensate analysis in diagnostics of occupational asthma and rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma. Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Altered exhaled biomarker profiles in children during and after rhinovirus-induced wheeze Source: Eur Respir J 2015; 45: 440-448 Year: 2015 Relationship between exhaled nitric oxide and exacerbation frequency in COPD patients: A longitudinal study Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011 Exhaled nitric oxide levels differ between allergic and non-allergic asthma in men, but not in women Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments? Year: 2011 Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways? Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 Exhaled breath temperature in patients with severe asthma starting treatment with omalizumab Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Exhaled breath condensate (EBC): changes in magnesium, pH and conductivity after exposure to swine house dust or inhaled LPS Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005